Document Detail

Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.
MedLine Citation:
PMID:  23212764     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: More than 40 % of patients with submucosal esophageal squamous cell carcinoma (ESCC) have lymph node metastasis. Furthermore, the potential presence of undetectable metastasis before treatment prompts surgeons to be aggressive with respect to lymph node dissection. Extending the indication for endoscopic resection, a minimally invasive treatment, to superficial ESCCs will require more accurate and individualized evaluation of lymph node metastasis.
METHODS: The study participants were 121 esophageal cancer patients who underwent curative surgery for thoracic submucosal ESCC at three Japanese hospitals. DNA was extracted from blood samples, and the C-reactive protein (CRP) 1846C>T genetic polymorphism (rs1205) was investigated using polymerase chain reaction-restriction fragment length polymorphism. We then evaluated the value of CRP 1846C>T polymorphism for diagnosis of lymph node metastasis.
RESULTS: Forty-nine (40 %) patients had lymph node metastasis. The CRP 1846 C/T genotype was C/C in 19 patients, C/T in 57 patients, and T/T in 45 patients. Fisher's exact analysis of the CRP 1846C>T polymorphism showed a significantly higher frequency of lymph node involvement with the T/T genotype. Univariate and multivariate logistic regression models revealed that patients carrying the 1846 T/T genotype had a significantly greater likelihood of developing lymph node metastasis (odds ratio >2.6). Combining the CRP 1846 C/T genotype with clinical diagnosis, mainly using CT, brought a negative predictive value of 80 % to diagnosing lymph node involvement.
CONCLUSIONS: CRP genetic polymorphism may be a novel predictor of risk of lymph node metastasis in ESCC, which could enable better evaluation of the necessity for lymph node dissection.
Satoru Motoyama; Kazuhiko Mori; Takashi Kamei; Masatomo Miura; Yudai Hinai; Yusuke Sato; Kei Yoshino; Tomohiko Sasaki; Go Miyata; Yasuyuki Seto; Jun-Ichi Ogawa
Related Documents :
24863944 - Relationship between chemotherapy and prognosis in different subtypes of node-negative ...
6723704 - Stage 1 and 2 carcinoma of the cervix: critical review of 140 cases treated in the deca...
24433754 - Combining smoking information and molecular markers improves prognostication in patient...
24403484 - Adjuvant radiotherapy for stage iii/iv urothelial carcinoma of the upper tract.
9166554 - Factors influencing survival after gamma knife radiosurgery for patients with single an...
19169034 - Possum predicts survival in patients with unresectable pancreatic cancer.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-12-05
Journal Detail:
Title:  Annals of surgical oncology     Volume:  20     ISSN:  1534-4681     ISO Abbreviation:  Ann. Surg. Oncol.     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-05-17     Completed Date:  2013-12-23     Revised Date:  2014-01-31    
Medline Journal Info:
Nlm Unique ID:  9420840     Medline TA:  Ann Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1978-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
C-Reactive Protein / genetics*
Carcinoma, Squamous Cell / diagnosis,  genetics*,  secondary*,  surgery
Esophageal Neoplasms / genetics*,  pathology*,  surgery
Kaplan-Meier Estimate
Logistic Models
Lymphatic Metastasis
Middle Aged
Multivariate Analysis
Odds Ratio
Polymorphism, Single Nucleotide
Predictive Value of Tests
Risk Factors
Tumor Markers, Biological / genetics*
Reg. No./Substance:
0/Tumor Markers, Biological; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malig...
Next Document:  Does Histologic Type Correlate to Outcome after Pelvic Exenteration for Cervical and Vaginal Cancer?